Cell Therapy Market Size and Share

The global cell therapy market size reached US$ 4.7 billion in 2023. Looking forward, Reports and Insights expects the market to reach US$ 13.4 billion in 2032, exhibiting a growth rate (CAGR) of 12.3% during 2024-2032.
Cell therapy (CT) is a groundbreaking field within regenerative medicine, and procedures involve the transplantation of living human cells to repair or replace damaged tissue and or cells. Different types of cells can be used as part of a therapy or treatment for a variety of diseases and conditions, as well as in sports medicine and severe burn care, and also can be used to prevent potential diseases. CT encompasses various technologies, solutions, and services aimed at harnessing the therapeutic potential of cells to repair, replace, or rejuvenate damaged tissues. Advancements in cell therapy have led to promising breakthroughs in treating conditions such as cancer, autoimmune disorders, and degenerative diseases. The approach often involves manipulating cells, either from the patient's own body (autologous) or from donors (allogeneic), to enhance their therapeutic properties.